USD 17.83
(-7.33%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 60.8 Million USD | -21.92% |
2022 | 77.87 Million USD | 43.55% |
2021 | 54.24 Million USD | 31.38% |
2020 | 41.29 Million USD | -1.48% |
2019 | 41.91 Million USD | -40.66% |
2018 | 70.64 Million USD | 41.79% |
2017 | 49.82 Million USD | 89.33% |
2016 | 26.31 Million USD | 83.69% |
2015 | 14.32 Million USD | -19.95% |
2014 | 17.89 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 93.04 Million USD | 130.15% |
2024 Q2 | 40.42 Million USD | -17.77% |
2024 Q1 | 49.16 Million USD | -19.14% |
2023 Q3 | 65.94 Million USD | -11.79% |
2023 FY | 60.8 Million USD | -21.92% |
2023 Q4 | 60.8 Million USD | -7.8% |
2023 Q2 | 74.75 Million USD | 6.46% |
2023 Q1 | 70.22 Million USD | -9.83% |
2022 Q4 | 77.87 Million USD | -11.07% |
2022 Q2 | 40.59 Million USD | 2.69% |
2022 FY | 77.87 Million USD | 43.55% |
2022 Q3 | 87.57 Million USD | 115.71% |
2022 Q1 | 39.53 Million USD | -27.12% |
2021 Q3 | 67.14 Million USD | -16.11% |
2021 FY | 54.24 Million USD | 31.38% |
2021 Q4 | 54.24 Million USD | -19.21% |
2021 Q2 | 80.03 Million USD | -0.64% |
2021 Q1 | 80.55 Million USD | 95.09% |
2020 FY | 41.29 Million USD | -1.48% |
2020 Q3 | 49.69 Million USD | -14.88% |
2020 Q2 | 58.38 Million USD | 83.35% |
2020 Q1 | 31.84 Million USD | -24.03% |
2020 Q4 | 41.29 Million USD | -16.91% |
2019 Q4 | 41.91 Million USD | -13.94% |
2019 FY | 41.91 Million USD | -40.66% |
2019 Q2 | 57.03 Million USD | -10.12% |
2019 Q3 | 48.7 Million USD | -14.61% |
2019 Q1 | 63.45 Million USD | -10.18% |
2018 Q3 | 32.72 Million USD | -17.21% |
2018 Q4 | 70.64 Million USD | 115.85% |
2018 FY | 70.64 Million USD | 41.79% |
2018 Q1 | 44.79 Million USD | -10.08% |
2018 Q2 | 39.52 Million USD | -11.76% |
2017 Q3 | 54.12 Million USD | 93.66% |
2017 Q2 | 27.94 Million USD | -2.19% |
2017 Q4 | 49.82 Million USD | -7.95% |
2017 FY | 49.82 Million USD | 89.33% |
2017 Q1 | 28.57 Million USD | 8.59% |
2016 Q4 | 26.31 Million USD | -8.73% |
2016 Q2 | 31.05 Million USD | 142.18% |
2016 Q3 | 28.83 Million USD | -7.17% |
2016 Q1 | 12.82 Million USD | -10.48% |
2016 FY | 26.31 Million USD | 83.69% |
2015 Q4 | 14.32 Million USD | -7.23% |
2015 FY | 14.32 Million USD | -19.95% |
2015 Q1 | - USD | -100.0% |
2015 Q3 | 15.44 Million USD | 0.0% |
2014 FY | 17.89 Million USD | 0.0% |
2014 Q4 | 17.89 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | 66.289% |
AngioDynamics, Inc. | 317.67 Million USD | 80.859% |
AtriCure, Inc. | 613.93 Million USD | 90.096% |
Avinger, Inc. | 13.77 Million USD | -341.569% |
Azenta, Inc. | 2.88 Billion USD | 97.893% |
BioLife Solutions, Inc. | 412.71 Million USD | 85.267% |
The Cooper Companies, Inc. | 11.65 Billion USD | 99.478% |
Daxor Corporation | 34.86 Million USD | -74.378% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | -110.264% |
Femasys Inc. | 27.75 Million USD | -119.068% |
GlucoTrack, Inc. | 4.9 Million USD | -1139.633% |
Harvard Bioscience, Inc. | 137.36 Million USD | 55.736% |
Hologic, Inc. | 9.15 Billion USD | 99.336% |
ICU Medical, Inc. | 4.37 Billion USD | 98.611% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 99.606% |
KORU Medical Systems, Inc. | 28.46 Million USD | -113.64% |
LeMaitre Vascular, Inc. | 346.77 Million USD | 82.466% |
Innovative Eyewear, Inc. | 6.21 Million USD | -877.751% |
Innovative Eyewear, Inc. | 6.21 Million USD | -877.751% |
Masimo Corporation | 3.04 Billion USD | 98.001% |
Microbot Medical Inc. | 8.32 Million USD | -630.203% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 64.631% |
Merit Medical Systems, Inc. | 2.32 Billion USD | 97.385% |
Nephros, Inc. | 11.86 Million USD | -412.638% |
NovoCure Limited | 1.14 Billion USD | 94.695% |
NEXGEL, Inc. | 9.95 Million USD | -510.789% |
NEXGEL, Inc. | 9.95 Million USD | -510.789% |
Singular Genomics Systems, Inc. | 265.46 Million USD | 77.095% |
OraSure Technologies, Inc. | 482.84 Million USD | 87.407% |
Pro-Dex, Inc. | 54.21 Million USD | -12.164% |
Predictive Oncology Inc. | 14.41 Million USD | -321.745% |
Precision Optics Corporation, Inc. | 16.91 Million USD | -259.519% |
QuidelOrtho Corporation | 8.56 Billion USD | 99.29% |
Repligen Corporation | 2.82 Billion USD | 97.847% |
Sanara MedTech Inc. | 73.87 Million USD | 17.689% |
STAAR Surgical Company | 488.69 Million USD | 87.558% |
Sharps Technology, Inc. | 11.78 Million USD | -415.757% |
Utah Medical Products, Inc. | 135.45 Million USD | 55.112% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.175% |
Jin Medical International Ltd. | 32.9 Million USD | -84.795% |